Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae

Aurélie Jayol^{1

2

3

4}, Patrice Nordmann^{1

2

3

5}, Laurent Poirel^{1

2

3}, Véronique Dubois^{4

6}

Affiliations

¹ Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland.
² INSERM European Unit (LEA-IAME Paris, France), University of Fribourg, Fribourg, Switzerland.
³ National Reference Center for Emerging Antibiotic Resistance, University of Fribourg, Fribourg, Switzerland.
⁴ Laboratory of Bacteriology, University Hospital of Bordeaux, Bordeaux, France.
⁵ University of Lausanne and University Hospital Center, Lausanne, Switzerland.
⁶ CNRS UMR5234, University of Bordeaux, Bordeaux, France.

Aurélie Jayol et al. J Antimicrob Chemother. 2018.

. 2018 Feb 1;73(2):542-544.

doi: 10.1093/jac/dkx393.

Aurélie Jayol^{1

2

3

4}, Patrice Nordmann^{1

2

3

5}, Laurent Poirel^{1

2

3}, Véronique Dubois^{4

6}

¹ Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland.
² INSERM European Unit (LEA-IAME Paris, France), University of Fribourg, Fribourg, Switzerland.
³ National Reference Center for Emerging Antibiotic Resistance, University of Fribourg, Fribourg, Switzerland.
⁴ Laboratory of Bacteriology, University Hospital of Bordeaux, Bordeaux, France.
⁵ University of Lausanne and University Hospital Center, Lausanne, Switzerland.
⁶ CNRS UMR5234, University of Bordeaux, Bordeaux, France.

No abstract available

Publication types